hocking-Samantha_edd

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)
A/Prof Samantha Hocking is an Endocrinologist at the Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. A/Prof Hocking’s main research interest is precision medicine exploring how personalised medicine can both predict, prevent and improve the management of metabolic disease, particularly diabetes. In addition, she is working with fellow researchers at The Boden Institute and the CPC-RPA Clinic on projects in obesity, bariatric surgery, metabolic syndrome and diabetes and liver disease.

More from this expert

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of Liraglutide 3mg in obesity management and patients who may benefit from it (5 mins).

Videos iconVideos

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Podcasts iconPodcasts

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

Podcasts iconPodcasts

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

Videos iconVideos

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

Podcasts iconPodcasts

A case-based approach with the latest developments on the incretin (GLP-1, GIP/GLP-1) front.

Videos iconVideos

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

Videos iconVideos

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Videos iconVideos

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

Clinical Articles iconClinical Articles

In this Product Explainer, A/Prof Samantha Hocking, Endocrinologist, explains the key changes to the tirzepatide KwikPen device, including operational steps, dosing considerations and patient counselling, with practical guidance for supporting safe and effective use (7 mins).

Videos iconVideos

Dr Angela Kwong is joined by A/Prof Samantha Hocking and Dr Georgia Rigas to unpack a case-based approach to obesity management in a 25-year-old woman using GLP-1 therapies.

Podcasts iconPodcasts

Upcoming Healthed Webcast

Practical Strategies for Behaviour Management in Dementia

Tuesday 7th July, 7pm - 9pm AEST

Speaker

Dr Chrys Pulle

Geriatrician; Principal Investigator, Internal Medicine and Dementia Research Unit, The Prince Charles Hospital

Dr Chrys Pulle provides practical and evidence-based recommendations on how best these behavioural and psychological symptoms can be assessed and managed.